Acusphere is a specialty pharmaceutical company focused on the development of its lead product candidate, Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension.

Imagify is a cardiovascular drug for the detection of coronary artery disease, the leading cause of death in Europe and the United States. Imagify was created using proprietary technology that enables Acusphere to control the porosity and size of nanoparticles and microspheres to be customized to address the delivery needs for myocardial perfusion assessment.

Contact Info

2 Canal Park, 5th Floor, Cambridge, MA, 02141
Tel: (617) 648-8800

Polaris Lead

Terry McGuire